Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Haoda Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5774-0742; OpenAlex author ID A5057340435. Sources: OpenAlex.

Their work

Papers
12 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2021: 3 papers · 2022: 3 papers · 2023: 5 papers · 2024: none · 2025: none · 2026: 1 paper

Papers 12

  1. LLPS-based classification and a novel prognostic signature reveal NRF1 as a therapeutic target in pancreatic cancer. Co-author DOI 10.1186/s12935-026-04395-z↗
  2. Real-world implications of nonbiological factors with staging, clinical management, and prognostic prediction in pancreatic ductal adenocarcinoma. First author DOI 10.1002/cam4.4910↗
  3. Risk factors for and prognostic values of postoperative acute kidney injury after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: A retrospective… Co-author DOI 10.1002/cam4.5543↗
  4. Health-related quality of life and survival outcomes for patients with major depressive disorder and anxiety: A longitudinal study in pancreatic ductal adenoca… First author DOI 10.1002/cam4.6577↗
  5. A deep-learning radiomics-based lymph node metastasis predictive model for pancreatic cancer: a diagnostic study. Co-author DOI 10.1097/js9.0000000000000469↗
  6. The Impact of Additional Para-aortic Dissection During Pancreaticoduodenectomy for Resectable Pancreatic Cancer. First author DOI 10.1245/s10434-022-12700-z↗
  7. Clinical characteristics and surgical outcomes of resectable acinar cell carcinoma of the pancreas-propensity score matching analysis with pancreatic ductal ad… Co-author DOI 10.1016/j.ejso.2021.11.135↗
  8. Oncological outcomes of robotic pancreatectomy in patients with pancreatic cancer who receive adjuvant chemotherapy: A propensity score-matched retrospective c… Co-author DOI 10.1016/j.ijsu.2022.106801↗
  9. Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: a retrospective cohort study. Co-author DOI 10.1186/s12885-022-09719-6↗
  10. Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection. Co-author DOI 10.1186/s12957-021-02281-8↗
  11. Preoperative Plasma D-Dimer Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Radical Resection Co-author DOI 10.21203/rs.3.rs-308863/v1↗
  12. Preoperative Score to Stratify Recurrence Risk After Curative Resection of Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Cohort Study Co-author DOI 10.21203/rs.3.rs-697919/v1↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Baiyong Shen · 9 shared papers, 2021–2023 · strength 1.60
  2. Xiaxing Deng · 9 shared papers, 2021–2023 · strength 1.52
  3. Weishen Wang · 5 shared papers, 2021–2026 · strength 0.93
  4. Ziyun Shen · 4 shared papers, 2022–2023 · strength 0.70
  5. Yuchen Ji · 3 shared papers, 2023 · strength 0.57
  6. Yiran Zhou · 3 shared papers, 2023 · strength 0.57
  7. Yuanchi Weng · 3 shared papers, 2022–2023 · strength 0.49
  8. Jun Zhang · 3 shared papers, 2021–2023 · strength 0.46
  9. Siyi Zou · 3 shared papers, 2021–2022 · strength 0.44
  10. Jiabin Jin · 2 shared papers, 2022–2026 · strength 0.42
  11. Chenghong Peng · 2 shared papers, 2022–2023 · strength 0.34
  12. Xinjing Wang · 2 shared papers, 2022 · strength 0.31
  13. Baiyong Shen · 2 shared papers, 2021–2022 · strength 0.30
  14. Hong Yu · 1 shared paper, 2026 · strength 0.26
  15. J S Liu · 1 shared paper, 2026 · strength 0.26
  16. Chao Wang · 1 shared paper, 2023 · strength 0.24
  17. Shulin Zhao · 1 shared paper, 2023 · strength 0.20
  18. Ningzhen Fu · 1 shared paper, 2023 · strength 0.19
  19. Hongzhe Li · 1 shared paper, 2023 · strength 0.19
  20. Xiaohua Qian · 1 shared paper, 2023 · strength 0.19
  21. Georgios Gemenetzis · 1 shared paper, 2022 · strength 0.16
  22. Jiewei Lin · 1 shared paper, 2022 · strength 0.15
  23. Xiongxiong Lu · 1 shared paper, 2022 · strength 0.15
  24. Qian Zhan · 1 shared paper, 2022 · strength 0.15
  25. Chenlei Wen · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.